Zevia offers asymmetric turnaround and acquisition upside at 0.6x sales, but weak execution, competition, dilution, and persistent losses make profitability proof essential.
Overview
Zevia PBC is a certified B Corp and public benefit corporation selling sugar-free, calorie-free, naturally sweetened carbonated beverages in recyclable aluminum cans. Its two continuing platforms are natural soda and plant-based energy drinks, following the Q2 2026 discontinuation of organic tea. The brand serves wellness-conscious consumers and families seeking lower sugar, with distribution across approximately 39,000 North American retail doors, including Walmart, Costco, and Albertsons. **The central investment issue is the gap between attractive strategic assets and weak standalone execution.** Q2 2026 net sales rose 1.1% year over year to $45.00 million, gross margin improved 20 basis points to 48.9%, and Adjusted EBITDA reached $0.52 million, but GAAP net loss widened to $2.91 million. Management maintained 2026 sales guidance of $170 million-$175 million, approximately 7% midpoint growth, while guiding to a $2.0 million-$4.0 million Adjusted EBITDA loss. Zevia trades at 0.6x trailing sales versus a 1.4x peer average, reflecting logistics costs, competition, dilution, and persistent losses. Near-term catalysts include Costco expansion, the Q1 2027 single-serve launch, $20.0 million of savings already delivered, additional supply-chain efficiencies, and activist pressure for a strategic sale. The principal valuation support is acquisition potential, as a buyer could integrate Zevia into a DSD network and eliminate redundant freight and warehousing costs.